NASDAQ:LOANManhattan Bridge Capital Stock Price, Forecast & News

Manhattan Bridge Capital's stock was trading at $5.08 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, LOAN shares have decreased by 9.1% and is now trading at $4.62. View which stocks have been most impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Manhattan Bridge Capital in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Manhattan Bridge Capital.

Manhattan Bridge Capital is scheduled to release its next quarterly earnings announcement on Friday, July 24th 2020. View our earnings forecast for Manhattan Bridge Capital.

Manhattan Bridge Capital Inc. (NASDAQ:LOAN) released its quarterly earnings data on Monday, April, 13th. The credit services provider reported $0.11 earnings per share for the quarter, hitting the Zacks' consensus estimate of $0.11. The credit services provider earned $1.71 million during the quarter. Manhattan Bridge Capital had a return on equity of 13.40% and a net margin of 60.44%. View Manhattan Bridge Capital's earnings history.

Manhattan Bridge Capital declared a quarterly dividend on Thursday, May 7th. Stockholders of record on Friday, July 10th will be given a dividend of $0.10 per share on Wednesday, July 15th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 8.66%. The ex-dividend date is Thursday, July 9th. View Manhattan Bridge Capital's dividend history.

2 Wall Street analysts have issued 1 year price targets for Manhattan Bridge Capital's stock. Their forecasts range from $6.00 to $6.00. On average, they anticipate Manhattan Bridge Capital's stock price to reach $6.00 in the next year. This suggests a possible upside of 29.9% from the stock's current price. View analysts' price targets for Manhattan Bridge Capital.

Press coverage about LOAN stock has trended somewhat positive this week, InfoTrie reports. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Manhattan Bridge Capital earned a media sentiment score of 1.7 on InfoTrie's scale. They also gave media stories about the credit services provider a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the near term. View the latest news aboutManhattan Bridge Capital.

Manhattan Bridge Capital saw a drop in short interest in May. As of May 15th, there was short interest totaling 7,300 shares, a drop of 19.8% from the April 30th total of 9,100 shares. Based on an average daily trading volume, of 53,700 shares, the short-interest ratio is currently 0.1 days. Approximately 0.1% of the shares of the company are sold short. View Manhattan Bridge Capital's Current Options Chain.

Some companies that are related to Manhattan Bridge Capital include Bluerock Residential Growth REIT Inc Class A (NYSEAMERICAN) (BRG), Anworth Mortgage Asset Corp Reit (ANH), Corenergy Infrastructure Trust (CORR), Cherry Hill Mortgage Investment (CHMI), CIM Commercial Trust (CMCT), Washington Prime Group (WPG), Drive Shack (DS), Maxus Realty Trust (MRTI), Clipper Realty (CLPR), Ellington Residential Mortgage REIT (EARN), Western Asset Mortgage Capital (WMC), Braemar Hotels & Resorts (BHR), AG Mortgage Investment Trust (MITT), Arlington Asset Investment (AI) and Pennsylvania R.E.I.T. (PEI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Manhattan Bridge Capital investors own include Allena Pharmaceuticals (ALNA), Energy Transfer LP Unit (ET), NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), AcelRx Pharmaceuticals (ACRX), Actinium Pharmaceuticals (ATNM), Dynex Capital (DX), Rigel Pharmaceuticals (RIGL), Saratoga Investment (SAR) and Two Harbors Investment (TWO).

Manhattan Bridge Capital trades on the NASDAQ under the ticker symbol "LOAN."

Manhattan Bridge Capital's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Shufro Rose & Co. LLC (1.19%), Hardy Reed LLC (0.76%), National Asset Management Inc. (0.59%), Advisor Group Holdings Inc. (0.12%) and Acadian Asset Management LLC (0.07%). Company insiders that own Manhattan Bridge Capital stock include Assaf Ran, Eran Goldshmit, Lyron L Bentovim and Vanessa Kao. View institutional ownership trends for Manhattan Bridge Capital.

LOAN stock was bought by a variety of institutional investors in the last quarter, including Hardy Reed LLC, Advisor Group Holdings Inc., Acadian Asset Management LLC, National Asset Management Inc., and Shufro Rose & Co. LLC. Company insiders that have bought Manhattan Bridge Capital stock in the last two years include Assaf Ran, and Vanessa Kao. View insider buying and selling activity for Manhattan Bridge Capital.

Shares of LOAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of LOAN stock can currently be purchased for approximately $4.62.

Manhattan Bridge Capital has a market capitalization of $44.49 million and generates $7.34 million in revenue each year. The credit services provider earns $4.49 million in net income (profit) each year or $0.47 on an earnings per share basis. Manhattan Bridge Capital employs 4 workers across the globe.

The official website for Manhattan Bridge Capital is www.manhattanbridgecapital.com.

Manhattan Bridge Capital's mailing address is 60 CUTTER MILL RD. SUITE 205, GREAT NECK NY, 11021. The credit services provider can be reached via phone at 516-444-3400.